IGXT Intelgenx Techs Corp

0.14
-0.02  -13%
Previous Close 0.16
Open 0.18
Price To Book 60.21
Market Cap 15,436,351
Shares 110,259,653
Volume 281,379
Short Ratio
Av. Daily Volume 902,618
Stock charts supplied by TradingView

NewsSee all news

  1. IntelGenx Announces Adjusted VersaFilm® Business Strategy, Next Steps for RIZAPORT® VersaFilm® Program

    SAINT LAURENT, Quebec, April 06, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced various

  2. IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA

    SAINT LAURENT, Quebec, March 27, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it

  3. IntelGenx Reports Fourth Quarter and Full-Year 2019 Financial Results

    SAINT LAURENT, Quebec, March 26, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter and

  4. INTELGENX TO REPORT FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS ON MARCH 26; CONFERENCE CALL TO FOLLOW ON MARCH 27

    SAINT LAURENT, Quebec, March 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) ("IntelGenx"), a leader in pharmaceutical films, today announced that it will release its fourth quarter and full-year

  5. IntelGenx Completes C$8.2 Million Equity Offering

    SAINT LAURENT, Quebec, Feb. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") is pleased to announce that it has closed its offering (the "Offering") of

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

CRL announced March 27, 2020.
RIZAPORT (RHB-103)
Migraine

Latest News

  1. IntelGenx Announces Adjusted VersaFilm® Business Strategy, Next Steps for RIZAPORT® VersaFilm® Program

    SAINT LAURENT, Quebec, April 06, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced various

  2. IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA

    SAINT LAURENT, Quebec, March 27, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it

  3. IntelGenx Reports Fourth Quarter and Full-Year 2019 Financial Results

    SAINT LAURENT, Quebec, March 26, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter and

  4. INTELGENX TO REPORT FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS ON MARCH 26; CONFERENCE CALL TO FOLLOW ON MARCH 27

    SAINT LAURENT, Quebec, March 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) ("IntelGenx"), a leader in pharmaceutical films, today announced that it will release its fourth quarter and full-year

  5. IntelGenx Completes C$8.2 Million Equity Offering

    SAINT LAURENT, Quebec, Feb. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") is pleased to announce that it has closed its offering (the "Offering") of

  6. IntelGenx Announces Pricing of Equity Offering

    SAINT LAURENT, Quebec, Jan. 27, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") announced today the pricing of an agency offering (the "Offering") of up to

  7. IntelGenx Receives Health Canada Authorization to Proceed with New Amendment for Montelukast VersaFilm® Phase 2a Trial

    - Ongoing BUENA Trial to Continue at Increased Daily Dose - SAINT LAURENT, Quebec, Jan. 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) ("IntelGenx"), a leader in pharmaceutical films, today

  8. IntelGenx Provides Commercial Update on its Two Lead VersaFilm® Product Candidates, Cannabis-Infused Oral Film and RIZAPORT®

    SAINT LAURENT, Quebec, Jan. 13, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) ("IntelGenx"), a leader in pharmaceutical films, today provided a commercial update on its two lead product candidates,

  9. IntelGenx Enters Animal Health Market by Signing Feasibility Agreement for VetaFilm™ Platform

    SAINT LAURENT, Quebec, Jan. 09, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) ("IntelGenx") a leader in pharmaceutical films, today announced that it has entered into a Feasibility Study Agreement

  10. IntelGenx Files Preliminary Short Form Prospectus in Connection With a Proposed Offering of Units

    SAINT LAURENT, Quebec, Dec. 19, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") is pleased to announce that it has filed a preliminary short form prospectus

  11. IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures

    SAINT LAURENT, Quebec, Dec. 06, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") announces that it intends to issue 415,178 common shares of the Corporation

  12. Kilmer Lucas Announces Agenda for BioTuesdays Pre-JPM Virtual Conference on December 10th

    CAMBRIDGE, ON / ACCESSWIRE / December 3, 2019 / Kilmer Lucas, a healthcare-focused investor relations and capital markets advisory firm, today announced the agenda for its first annual BioTuesdays Pre-JPM Virtual

  13. IntelGenx to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

    SAINT LAURENT, Quebec, Dec. 03, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that

  14. IntelGenx Reports Third Quarter 2019 Financial Results

    SAINT LAURENT, Quebec, Nov. 07, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today reported financial

  15. IntelGenx to Report Third Quarter 2019 Financial Results on November 7, 2019 – Conference Call to Follow

    SAINT LAURENT, Quebec, Nov. 01, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it

  16. IntelGenx Initiates Scale-Up Work for Cannabis-Infused Oral Film Product

    SAINT LAURENT, Quebec, Oct. 31, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it has progressed

  17. IntelGenx Receives Positive DSMB Recommendation for Montelukast VersaFilm® Phase 2a Trial

    - With No Safety Concerns, DSMB Recommends Trial Continues; Dose Increase Planned - SAINT LAURENT, Quebec, Oct. 09, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX)(OTCQX:IGXT) (the "Company" or

  18. IntelGenx Announces Resubmission of RIZAPORT® New Drug Application

    SAINT LAURENT, Quebec, Sept. 26, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that it has resubmitted

  19. IntelGenx to Present at the H.C. Wainwright 21st Annual Global Investment Conference

    SAINT LAURENT, Quebec, Sept. 03, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that its